Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel Therapeutic Options for Small Cell Lung Cancer.
Canova S, Trevisan B, Abbate MI, Colonese F, Sala L, Baggi A, Bianchi SP, D'Agostino A, Cortinovis DL. Canova S, et al. Among authors: abbate mi. Curr Oncol Rep. 2023 Nov;25(11):1277-1294. doi: 10.1007/s11912-023-01465-7. Epub 2023 Oct 23. Curr Oncol Rep. 2023. PMID: 37870696 Free PMC article. Review.
Targeted therapies and immunotherapy in non-small-cell lung cancer.
Cortinovis D, Abbate M, Bidoli P, Capici S, Canova S. Cortinovis D, et al. Ecancermedicalscience. 2016 Jun 23;10:648. doi: 10.3332/ecancer.2016.648. eCollection 2016. Ecancermedicalscience. 2016. PMID: 27433281 Free PMC article. Review.
A new race against lung cancer.
Cortinovis D, Canova S, Abbate MI, Colonese F, Bidoli P. Cortinovis D, et al. Among authors: abbate mi. J Vis Surg. 2017 Aug 21;3:110. doi: 10.21037/jovs.2017.07.01. eCollection 2017. J Vis Surg. 2017. PMID: 29078670 Free PMC article. No abstract available.
Harnessing DLL3 inhibition: From old promises to new therapeutic horizons.
Cortinovis DL, Colonese F, Abbate MI, Sala L, Meazza Prina M, Cordani N, Sala E, Canova S. Cortinovis DL, et al. Among authors: abbate mi. Front Med (Lausanne). 2022 Dec 1;9:989405. doi: 10.3389/fmed.2022.989405. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36530878 Free PMC article. Review.
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma.
Canova S, Ceresoli GL, Grosso F, Zucali PA, Gelsomino F, Pasello G, Mencoboni M, Rulli E, Galli F, De Simone I, Carlucci L, De Angelis A, Belletti M, Bonomi M, D'Aveni A, Perrino M, Bono F, Cortinovis DL; DIADEM groupD. Canova S, et al. ESMO Open. 2022 Dec;7(6):100644. doi: 10.1016/j.esmoop.2022.100644. Epub 2022 Dec 1. ESMO Open. 2022. PMID: 36463732 Free PMC article. Clinical Trial.
13 results